These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6288390)

  • 1. VP16-213 in combined modality treatment of small cell carcinoma of the lung.
    Newman SB; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Raghavan V
    Eur J Cancer Clin Oncol; 1982 Apr; 18(4):343-6. PubMed ID: 6288390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin, Cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer.
    Aisner J; Whitacre M; VanEcho DA; Wesley M; Wiernik PH
    Cancer Chemother Pharmacol; 1982; 7(2-3):187-93. PubMed ID: 6282482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epipodophyllotoxin (VP16-213) in small cell carcinoma of the Bronchus resistant to initial combination chemotherapy.
    Harper PG; Dally MB; Geddes DM; Spiro SG; Smyth JF; Souhami RL
    Cancer Chemother Pharmacol; 1982; 7(2-3):179-80. PubMed ID: 6282480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy.
    Cortés Funes H; Dominguez P; Torrubia AP; Lanzos E; Mendez M; Mendiola C
    Cancer Chemother Pharmacol; 1982; 7(2-3):181-6. PubMed ID: 6282481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
    Perez Manga G; Madrigal Alonso P; Alburquerque Carbuccia H
    Cancer Chemother Pharmacol; 1982; 7(2-3):231-3. PubMed ID: 6896298
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy.
    Goodman GE; Miller TP; Manning MM; Davis SL; McMahon LJ
    J Clin Oncol; 1983 Aug; 1(8):483-8. PubMed ID: 6321685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
    Jackson DV; Zekan PJ; Caldwell RD; Slatkoff ML; Harding RW; Case LD; Hopkins JO; Muss HB; Richards F; White DR
    J Clin Oncol; 1984 Dec; 2(12):1343-51. PubMed ID: 6096517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
    Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
    Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study].
    Schütte J; Niederle N; Eberhardt W; Seeber S; Alberti W; Budach V; Hirche H; Schmidt CG
    Klin Wochenschr; 1989 Dec; 67(23):1182-93. PubMed ID: 2558254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vincristine, Adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung.
    von Eyben FE; Arwidi A; Hellekant C; Jonsson K; Lindahl SA; Mattsson W; Tennvall L
    Cancer Chemother Pharmacol; 1982; 7(2-3):195-7. PubMed ID: 6282483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL).
    Gracia JM; Jimenez A
    Cancer Chemother Pharmacol; 1982; 7(2-3):199-201. PubMed ID: 6282484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinoma.
    Morasca L; Marsoni S; Pisoni MB; Piazza E; Vago G; Casali W; Cogo R; Bianchi C; Scapaticci R
    Cancer Chemother Pharmacol; 1982; 7(2-3):209-10. PubMed ID: 7083461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced radiation reaction following combination chemotherapy for small cell carcinoma of the lung, possibly secondary to VP16-213.
    Giever RJ; Heusinkveld RS; Manning MR; Bowden GT
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):921-3. PubMed ID: 6286559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.